GH-2024-JP-Morgan-Conference-Presentation-Final.pdf

《GH-2024-JP-Morgan-Conference-Presentation-Final.pdf》由会员分享，可在线阅读，更多相关《GH-2024-JP-Morgan-Conference-Presentation-Final.pdf（36页珍藏版）》请在三个皮匠报告上搜索。

1、Transforming Cancer CareJ.P.Morgan Healthcare ConferenceJanuary 8,2024Safe harbor2Certain statements in this presentation and the accompanying oral commentary are forward-looking statements within the meaning of federal securities laws.These statements relate to future events or Guardant Health,Inc.

2、(the“Company”)s future results and involve known and unknown risks,uncertainties and other factors that may cause the actual results,levels of activity,performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking stateme

3、nts.In some cases,forward-looking statements can be identified by terminology such as“may,”“will,”“could,”“would,”“should,”“to,”“target,”“expect,”“plan,”“anticipate,”“intend,”“believe,”“estimate,”“predict,”“potential”or other comparable terminology.All statements other than statements of historical

4、fact could be deemed forward-looking,including any expectations regarding the Companys commercial engine as a force multiplier for research and development initiatives;any projections of market opportunities;statements about the Companys ability to assess potential market opportunities or any statem

5、ents about the Companys ability to successfully develop new products and services;any statements regarding expectations for future reimbursement opportunities;any statements regarding the Companys long-term expectations,including with respect to oncology,liquid biopsy,and other aspects of the Compan

6、ys industry;any statements about launching planned new products and additional laboratories,including with respect to Guardant Reveal,CGP tissue assay,and laboratories outside the United States;any statements about the Companys ECLIPSE study;any statements regarding expectations for future regulator